This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Procter & Gamble (PG) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Procter & Gamble (PG) closed the most recent trading day at $148.08, moving -0.52% from the previous trading session.
Should You Invest in the Vanguard Consumer Staples ETF (VDC)?
by Zacks Equity Research
Sector ETF report for VDC
Is Fidelity High Dividend ETF (FDVV) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FDVV
Why You Must Consider Colgate (CL) Stock Before Q2 Earnings
by Zacks Equity Research
Colgate (CL) is well-poised on its innovation efforts, pricing actions, digital capabilities and progress on revenue growth management initiatives.
Should You Invest in the Fidelity MSCI Consumer Staples Index ETF (FSTA)?
by Zacks Equity Research
Sector ETF report for FSTA
Constellation Brands (STZ) Q1 Earnings & Sales Top Estimates
by Zacks Equity Research
Constellation Brands' (STZ) Q1 results reflect strength in its beer business and cost-efficiency initiatives. As a result, it retains the fiscal 2024 view.
Procter & Gamble (PG) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Procter & Gamble (PG) closed at $149.38, marking a -0.41% move from the previous day.
Investors Heavily Search Procter & Gamble Company (The) (PG): Here is What You Need to Know
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to P&G (PG). This makes it worthwhile to examine what the stock has in store.
Clorox (CLX) Surpasses the Industry in a Year: Here's How
by Zacks Equity Research
Clorox (CLX) is poised to benefit from pricing gains and cost savings efforts, along with a solid innovation pipeline, digital transformation and its IGNITE strategy.
Here's Why Molson Coors (TAP) is Marching Ahead of Its Industry
by Zacks Equity Research
Although rising inflation is concerning, brand strength, product innovation and a revitalization plan bode well for Molson Coors (TAP).
5 Blue-Chip Stocks to Buy Amid a Muted Dow in First-Half 2023
by Nalak Das
We have narrowed our search to five blue-chip (components of Dow) stocks with strong potential for 2023. These are: CAT, CRM, WMT, PG and MCD.
Can Growth Efforts Counter Boston Beer's (SAM) Supply-Chain Woes?
by Zacks Equity Research
Although drab seltzer unit, dismal shipments and depletions, and cost woes remain concerning, pricing actions, product innovation and cost-saving efforts are likely to aid Boston Beer (SAM).
Procter & Gamble (PG) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Procter & Gamble (PG) closed the most recent trading day at $148.46, moving -0.99% from the previous trading session.
Graphic Package Holding and Vornado Realty have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Graphic Package Holding and Vornado Realty have been highlighted as Zacks Bull and Bear of the Day.
3 Low-Beta Stocks Suited Nicely for Risk-Averse Investors
by Derek Lewis
Low-beta stocks are less susceptible to the broader market's movements, helping to limit those spooky price swings. And interestingly enough, analysts have recently become bullish on these three.
Brown-Forman (BF.B) to Sell Finlandia Vodka to Coca-Cola HBC
by Zacks Equity Research
Brown-Forman (BF.B) enters a deal to sell the Finlandia vodka brand to Coca-Cola HBC, following the brand's bleak prospects post the exit of its Russia operations.
Here's Why Procter & Gamble (PG) is an Attractive Pick Now
by Zacks Equity Research
Procter & Gamble (PG) is a lucrative pick on its ongoing business momentum, strength across businesses, pricing actions and productivity plans.
Here's Why Brown-Forman (BF.B) is Marching Ahead of Its Industry
by Zacks Equity Research
Brown-Forman (BF.B) is poised for growth on solid brand demand, acquisitions, portfolio premiumization, product innovation and strategic relationships amid cost headwinds.
Zacks Investment Ideas feature highlights: Adobe, McDonalds, Pepsi and Procter and Gamble
by Zacks Equity Research
Adobe, McDonalds, Pepsi and Procter and Gamble are part of the Zacks Investment Ideas article.
Time to Buy These 4 Stocks with Multi-Decade Earnings Growth?
by Ethan Feller
Steady can sometimes be boring, but in investing, boring is profitable
Colgate (CL) Looks Solid on Pricing Action & Expansion Strategy
by Zacks Equity Research
Pricing actions, revenue management initiatives, innovation, brand strength and digital growth position Colgate (CL) for growth amid higher costs and currency headwinds.
Procter & Gamble Company (The) (PG) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
P&G (PG) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
P&G (PG) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
The average brokerage recommendation (ABR) for P&G (PG) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Procter & Gamble (PG) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Procter & Gamble (PG) closed at $145.06, marking a -0.24% move from the previous day.
Top Stock Reports for Procter & Gamble, Bank of America & Abbott Laboratories
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including The Procter & Gamble Company (PG), Bank of America Corporation (BAC) and Abbott Laboratories (ABT).